SCHEMBL9156429

SCHEMBL9156429

C[C@@H](Cc1cccc(C(F)(F)F)c1)NCc1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 4/20 0.74
▸ HTR2A P28223 3/20 0.74
▸ HTR2B P41595 3/20 0.74
▸ ADRA2C P18825 2/20 0.74
▸ SLC6A4 P31645 2/20 0.74
▸ ADRA1A P35348 2/20 0.74
▸ DRD3 P35462 2/20 0.74
▸ LMNA P02545 2/20 0.74
▸ MAPT P10636 2/20 0.74
▸ OPRK1 P41145 1/20 0.74
▸ CYP3A4 P08684 3/20 0.71
▸ CYP1A2 P05177 2/20 0.71
▸ CYP2D6 P10635 2/20 0.71
▸ TP53 P04637 1/20 0.71
▸ TSHR P16473 1/20 0.71
▸ CYP2C19 P33261 1/20 0.71
▸ HTR2C P28335 2/20 0.61
▸ USP2 O75604 2/20 0.61
▸ NR1I2 O75469 1/20 0.61
▸ ADRB1 P08588 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9248064 1.00 SIGMAR1 (0.74) SIGMAR1HTR2AHTR2BADRA2CSLC6A4
SCHEMBL9472690 1.00 SIGMAR1 (0.74) SIGMAR1HTR2AHTR2BADRA2CSLC6A4
SCHEMBL21632672 0.86 SIGMAR1 (0.85) SIGMAR1HTR2AHTR2BADRA2CSLC6A4
Fenfluramine SCHEMBL8196727 0.85 SIGMAR1 (0.94) SIGMAR1HTR2AHTR2BADRA2CSLC6A4
Fenfluramine SCHEMBL29447403 0.85 SLC6A4 (1.00) SIGMAR1HTR2AHTR2BADRA2CSLC6A4
Fenfluramine SCHEMBL16215 0.85 SLC6A4 (1.00) SIGMAR1HTR2AHTR2BADRA2CSLC6A4
Dexfenfluramine SCHEMBL16706 0.85 SLC6A4 (1.00) SIGMAR1HTR2AHTR2BADRA2CSLC6A4
Levofenfluramine SCHEMBL29882976 0.85 SLC6A4 (1.00) SIGMAR1HTR2AHTR2BADRA2CSLC6A4
Dexfenfluramine SCHEMBL15669714 0.85 SLC6A4 (1.00) SIGMAR1HTR2AHTR2BADRA2CSLC6A4
Levofenfluramine SCHEMBL162006 0.85 SLC6A4 (1.00) SIGMAR1HTR2AHTR2BADRA2CSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0543713-B1 Ethanolamine benzoate derivatives, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 1995-02-22 — — EP disclosed
US-5266591-A For treatment of abnormal metabolism ADIR ET COMPAGNIE (FR) 1993-11-30 — — US disclosed
EP-0543713-A1 Ethanolamine benzoate derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1993-05-26 — — EP disclosed
Send feedback